65 Results Related to "Photopheresis"

Photopheresis (also known as extracorporeal photochemotherapy, ECP) is a blood-filtering treatment that works with your body’s own immune system to treat disease.

Cutaneous T-cell lymphoma (CTCL) is a relatively rare type of non-Hodgkin lymphoma cancer that causes white blood cells to multiply too quickly.

Skin lymphoma is a relatively rare skin cancer unrelated to sun exposure. Yale Medicine treatment options include total skin electron beam therapy (TSEB).

Psoriasis is an autoimmune disease that results in red, scaly, itchy patches of skin. Its roots are both genetic and environmental.

Eczema is the diagnosis for chronic dry skin that brings extremely itchy, pink skin or red rashes. It's common in kids, but adults get eczema too.

Lymphoma refers to a group of blood cancers, of which the two most common include: Hodgkin lymphoma and non-Hodgkin lymphoma.

Radiation therapy may be used to relieve pain or other symptoms related to lymphoma, such as if a tumor has spread to the brain or is pressing on nerves.

Effective surgical treatment for melanoma can help patients diagnosed with this deadly cancer to live a long and healthy life.

An actinic keratosis (AK) appears as a small, pink, scaly patch on the skin. Raising the risk of skin cancer, AK is common and is caused by sun exposure.

Photodynamic therapy uses blue fluorescent light (no surgery or needles) to eradicate precancerous cells caused by sun exposure.

More than 80 percent of children diagnosed with cancer are cured, and chemotherapy is an effective treatment for childhood cancer.

Doctors only diagnose cancer after ruling out other possible causes for symptoms and performing tests to check and double-check the diagnosis.

Pharyngeal cancer affects the back of the throat (pharynx), and oropharyngeal cancer affects the back of the tongue, tonsils, soft palate and part of the throat.

Immunotherapy works in one of two ways—it can boost mechanisms of the immune system so that it has more strength to fight cancer cells. Or, it can target and destroy certain receptors on cancer cells to prevent them from outsmarting the immune system.

Basal cell carcinoma accounts for 80 percent of all skin cancers. The cause is damage to the DNA of cells in the epidermis, the top layer of the skin.